Centennial Medical Group
Elkridge, Maryland
We've found
8 trials
at this facility
Influenza A Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Benign Prostatic Hyperplasia Clinical Trial
Updated: 4/23/2018
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Influenza, Human Clinical Trial
Updated: 12/31/1969
A Clinical Trial of KT07 Capsule in the U.S.A
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/31/1969
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/31/1969
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colo-rectal Cancer Clinical Trial
Updated: 12/31/1969
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Insomnia Disorders Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
Updated: 12/31/1969
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials